ID   PA24B_HUMAN             Reviewed;         781 AA.
AC   P0C869; B4DRT9; O95712; Q19KD5; Q19KD6; Q59GF9; Q8TB10; Q9UKV7;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   10-MAY-2017, entry version 86.
DE   RecName: Full=Cytosolic phospholipase A2 beta;
DE            Short=cPLA2-beta;
DE            EC=3.1.1.4;
DE   AltName: Full=Phospholipase A2 group IVB;
GN   Name=PLA2G4B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF SER-335; HIS-417; ASP-615 AND ARG-632.
RX   PubMed=10085124; DOI=10.1074/jbc.274.13.8823;
RA   Pickard R.T., Strifler B.A., Kramer R.M., Sharp J.D.;
RT   "Molecular cloning of two new human paralogs of 85-kDa cytosolic
RT   phospholipase A2.";
RL   J. Biol. Chem. 274:8823-8831(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), FUNCTION, CATALYTIC ACTIVITY,
RP   ENZYME REGULATION, AND TISSUE SPECIFICITY.
RX   PubMed=10358058; DOI=10.1074/jbc.274.24.17063;
RA   Song C., Chang X.J., Bean K.M., Proia M.S., Knopf J.L., Kriz R.W.;
RT   "Molecular characterization of cytosolic phospholipase A2-beta.";
RL   J. Biol. Chem. 274:17063-17067(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, CATALYTIC
RP   ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16617059; DOI=10.1074/jbc.M601770200;
RA   Ghosh M., Loper R., Gelb M.H., Leslie C.C.;
RT   "Identification of the expressed form of human cytosolic phospholipase
RT   A2beta (cPLA2beta): cPLA2beta3 is a novel variant localized to
RT   mitochondria and early endosomes.";
RL   J. Biol. Chem. 281:16615-16624(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   CYS-191.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
CC   -!- FUNCTION: Calcium-dependent phospholipase A2 that selectively
CC       hydrolyzes glycerophospholipids in the sn-2 position with a
CC       preference for arachidonoyl phospholipids. Has a much weaker
CC       activity than PLA2G4A. Isoform 3 has calcium-dependent activity
CC       against palmitoyl-arachidonyl-phosphatidylethanolamine and low
CC       level lysophospholipase activity but no activity against
CC       phosphatidylcholine. Isoform 5 does have activity against
CC       phosphatidylcholine. {ECO:0000269|PubMed:10085124,
CC       ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:16617059}.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC       {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058,
CC       ECO:0000269|PubMed:16617059}.
CC   -!- ENZYME REGULATION: Stimulated by cytosolic Ca(2+).
CC       {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=7.9 pmol/min/mg enzyme (isoform 5)
CC         {ECO:0000269|PubMed:10085124};
CC         Vmax=3.6 pmol/min/ug enzyme with cAMP as substrate (isoform 4)
CC         {ECO:0000269|PubMed:10085124};
CC         Vmax=140 nmol/min/ug enzyme with 1-[14C]16:0-2-lyso-PC as
CC         substrate (isoform 5) {ECO:0000269|PubMed:10085124};
CC         Vmax=1.6 nmol/min/ug enzyme with 1-[14C]16:0-2-lyso-PC as
CC         substrate (isoform 3) {ECO:0000269|PubMed:10085124};
CC         Vmax=2.1 nmol/min/ug enzyme with 1-16:0-2-[14C]20:4-PC as
CC         substrate (isoform 5) {ECO:0000269|PubMed:10085124};
CC         Vmax=0.6 nmol/min/ug enzyme with 1-16:0-2-[14C]20:4-PE as
CC         substrate (isoform 5) {ECO:0000269|PubMed:10085124};
CC         Vmax=0.8 nmol/min/ug enzyme with 1-16:0-2-[14C]20:4-PE as
CC         substrate (isoform 3) {ECO:0000269|PubMed:10085124};
CC         Vmax=0.3 nmol/min/ug enzyme with 1-16:0-2-[14C]18:2-PE as
CC         substrate (isoform 3) {ECO:0000269|PubMed:10085124};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:16617059}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane;
CC       Peripheral membrane protein. Early endosome membrane; Peripheral
CC       membrane protein. Note=Translocates to membrane vesicles in a
CC       calcium-dependent fashion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P0C869-1, O95712-1;
CC         Sequence=Displayed;
CC       Name=2; Synonyms=beta2;
CC         IsoId=P0C869-7; Sequence=VSP_039387, VSP_039389, VSP_039390;
CC         Note=Based on a naturally occurring readthrough transcript which
CC         produces a JMJD7-PLA2G4B fusion protein.;
CC       Name=3; Synonyms=beta3;
CC         IsoId=P0C869-8; Sequence=VSP_039387, VSP_039388;
CC         Note=Based on a naturally occurring readthrough transcript which
CC         produces a JMJD7-PLA2G4B fusion protein.;
CC       Name=4;
CC         IsoId=P0C869-4, O95712-4;
CC         Sequence=VSP_019871;
CC         Note=No experimental confirmation available.;
CC       Name=5; Synonyms=Beta1;
CC         IsoId=P0C869-6; Sequence=VSP_039387;
CC         Note=Based on a naturally occurring readthrough transcript which
CC         produces a JMJD7-PLA2G4B fusion protein.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in
CC       brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely
CC       expressed. {ECO:0000269|PubMed:10085124,
CC       ECO:0000269|PubMed:10358058, ECO:0000269|PubMed:16617059}.
CC   -!- DOMAIN: The N-terminal C2 domain associates with lipid membranes
CC       upon calcium binding. It modulates enzyme activity by presenting
CC       the active site to its substrate in response to elevations of
CC       cytosolic Ca(2+) (By similarity). {ECO:0000250}.
CC   -!- CAUTION: Most tissues also express read-through transcripts from
CC       this gene into the upstream gene (JMJD7), some of which may encode
CC       fusion proteins. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92387.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF065215; AAC78836.1; -; mRNA.
DR   EMBL; AF121908; AAD32135.1; -; mRNA.
DR   EMBL; DQ523799; ABF69195.1; -; mRNA.
DR   EMBL; DQ523800; ABF69196.1; -; mRNA.
DR   EMBL; AK299419; BAG61401.1; -; mRNA.
DR   EMBL; AB209150; BAD92387.1; ALT_INIT; mRNA.
DR   EMBL; AC020659; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS45241.1; -.
DR   RefSeq; NP_001108105.1; NM_001114633.1. [P0C869-1]
DR   RefSeq; NP_001185517.1; NM_001198588.1. [P0C869-7]
DR   RefSeq; NP_005081.1; NM_005090.3. [P0C869-6]
DR   UniGene; Hs.198161; -.
DR   ProteinModelPortal; P0C869; -.
DR   SMR; P0C869; -.
DR   BioGrid; 114229; 2.
DR   BioGrid; 936685; 4.
DR   IntAct; P0C869; 3.
DR   STRING; 9606.ENSP00000396045; -.
DR   BindingDB; P0C869; -.
DR   ChEMBL; CHEMBL4136; -.
DR   SwissLipids; SLP:000000616; -. [P0C869-8]
DR   SwissLipids; SLP:000000617; -. [P0C869-6]
DR   iPTMnet; P0C869; -.
DR   PhosphoSitePlus; P0C869; -.
DR   BioMuta; PLA2G4B; -.
DR   DMDM; 300669659; -.
DR   EPD; P0C869; -.
DR   MaxQB; P0C869; -.
DR   PaxDb; P0C869; -.
DR   PeptideAtlas; P0C869; -.
DR   PRIDE; P0C869; -.
DR   DNASU; 8681; -.
DR   Ensembl; ENST00000452633; ENSP00000396045; ENSG00000243708. [P0C869-1]
DR   Ensembl; ENST00000458483; ENSP00000416610; ENSG00000243708. [P0C869-1]
DR   GeneID; 100137049; -.
DR   GeneID; 8681; -.
DR   KEGG; hsa:100137049; -.
DR   KEGG; hsa:8681; -.
DR   UCSC; uc010bco.4; human.
DR   CTD; 100137049; -.
DR   CTD; 8681; -.
DR   DisGeNET; 100137049; -.
DR   DisGeNET; 8681; -.
DR   GeneCards; PLA2G4B; -.
DR   HGNC; HGNC:9036; PLA2G4B.
DR   HPA; HPA005726; -.
DR   MIM; 606088; gene.
DR   neXtProt; NX_P0C869; -.
DR   OpenTargets; ENSG00000168970; -.
DR   OpenTargets; ENSG00000243708; -.
DR   PharmGKB; PA165479070; -.
DR   eggNOG; KOG1028; Eukaryota.
DR   eggNOG; KOG1325; Eukaryota.
DR   eggNOG; ENOG410XR72; LUCA.
DR   GeneTree; ENSGT00550000074489; -.
DR   HOVERGEN; HBG080412; -.
DR   InParanoid; P0C869; -.
DR   KO; K16342; -.
DR   OMA; YNICNNQ; -.
DR   OrthoDB; EOG091G011T; -.
DR   PhylomeDB; P0C869; -.
DR   TreeFam; TF325228; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483115; Hydrolysis of LPC.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   GeneWiki; PLA2G4B; -.
DR   PRO; PR:P0C869; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000243708; -.
DR   ExpressionAtlas; P0C869; baseline and differential.
DR   Genevisible; P0C869; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; TAS:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; IDA:UniProtKB.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; NAS:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; TAS:Reactome.
DR   GO; GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; TAS:Reactome.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; NAS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; NAS:UniProtKB.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; NAS:UniProtKB.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0007567; P:parturition; NAS:UniProtKB.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:Reactome.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR002642; LysoPLipase_cat_dom.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF01735; PLA2_B; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00022; PLAc; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS51210; PLA2C; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Cytoplasm; Endosome;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Membrane;
KW   Metal-binding; Mitochondrion; Polymorphism; Reference proteome.
FT   CHAIN         1    781       Cytosolic phospholipase A2 beta.
FT                                /FTId=PRO_0000247021.
FT   DOMAIN        1     97       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      246    781       PLA2c. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00555}.
FT   ACT_SITE    335    335       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    615    615       Proton acceptor. {ECO:0000250}.
FT   VAR_SEQ       1    299       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_019871.
FT   VAR_SEQ       1      3       MAV -> MAEAALEAVRSELREFPAAARELCVPLAVPYLDK
FT                                PPTPLHFYRDWVCPNRPCIIRNALQHWPALQKWSLPYFRAT
FT                                VGSTEVSVAVTPDGYADAVRGDRFMMPAERRLPLSFVLDVL
FT                                EGRAQHPGVLYVQKQCSNLPSELPQLLPDLESHVPWASEAL
FT                                GKMPDAVNFWLGEAAAVTSLHKDHYENLYCVVSGEKHFLFH
FT                                PPSDRPFIPYELYTPATYQLTEEGTFKVVDEEAMEK (in
FT                                isoform 2, isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:10085124,
FT                                ECO:0000303|PubMed:10358058,
FT                                ECO:0000303|PubMed:16617059}.
FT                                /FTId=VSP_039387.
FT   VAR_SEQ     641    765       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:16617059}.
FT                                /FTId=VSP_039388.
FT   VAR_SEQ     650    662       QLQLLGRFCQEQG -> GSGGHPRRRQLGR (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:16617059}.
FT                                /FTId=VSP_039389.
FT   VAR_SEQ     663    781       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16617059}.
FT                                /FTId=VSP_039390.
FT   VARIANT     191    191       R -> C (in dbSNP:rs3816533).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_027047.
FT   VARIANT     239    239       M -> I (in dbSNP:rs2290552).
FT                                /FTId=VAR_027048.
FT   VARIANT     391    391       R -> H (in dbSNP:rs34807597).
FT                                /FTId=VAR_034365.
FT   VARIANT     591    591       T -> I (in dbSNP:rs36126315).
FT                                /FTId=VAR_060082.
FT   MUTAGEN     335    335       S->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   MUTAGEN     417    417       H->A: No effect.
FT                                {ECO:0000269|PubMed:10085124}.
FT   MUTAGEN     615    615       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   MUTAGEN     632    632       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   CONFLICT    138    138       L -> F (in Ref. 2; AAD32135).
FT                                {ECO:0000305}.
FT   CONFLICT    162    162       Q -> P (in Ref. 3; ABF69195/ABF69196).
FT                                {ECO:0000305}.
FT   CONFLICT    438    438       A -> V (in Ref. 3; ABF69195).
FT                                {ECO:0000305}.
FT   CONFLICT    517    517       S -> P (in Ref. 3; ABF69195).
FT                                {ECO:0000305}.
FT   CONFLICT    575    575       R -> C (in Ref. 4; BAG61401).
FT                                {ECO:0000305}.
FT   CONFLICT    723    723       G -> E (in Ref. 4; BAG61401).
FT                                {ECO:0000305}.
SQ   SEQUENCE   781 AA;  87978 MW;  4C5C6861E7BAB1B8 CRC64;
     MAVAEVSRTC LLTVRVLQAH RLPSKDLVTP SDCYVTLWLP TACSHRLQTR TVKNSSSPVW
     NQSFHFRIHR QLKNVMELKV FDQDLVTGDD PVLSVLFDAG TLRAGEFRRE SFSLSPQGEG
     RLEVEFRLQS LADRGEWLVS NGVLVARELS CLHVQLEETG DQKSSEHRVQ LVVPGSCEGP
     QEASVGTGTF RFHCPACWEQ ELSIRLQDAP EEQLKAPLSA LPSGQVVRLV FPTSQEPLMR
     VELKKEAGLR ELAVRLGFGP CAEEQAFLSR RKQVVAAALR QALQLDGDLQ EDEIPVVAIM
     ATGGGIRAMT SLYGQLAGLK ELGLLDCVSY ITGASGSTWA LANLYEDPEW SQKDLAGPTE
     LLKTQVTKNK LGVLAPSQLQ RYRQELAERA RLGYPSCFTN LWALINEALL HDEPHDHKLS
     DQREALSHGQ NPLPIYCALN TKGQSLTTFE FGEWCEFSPY EVGFPKYGAF IPSELFGSEF
     FMGQLMKRLP ESRICFLEGI WSNLYAANLQ DSLYWASEPS QFWDRWVRNQ ANLDKEQVPL
     LKIEEPPSTA GRIAEFFTDL LTWRPLAQAT HNFLRGLHFH KDYFQHPHFS TWKATTLDGL
     PNQLTPSEPH LCLLDVGYLI NTSCLPLLQP TRDVDLILSL DYNLHGAFQQ LQLLGRFCQE
     QGIPFPPISP SPEEQLQPRE CHTFSDPTCP GAPAVLHFPL VSDSFREYSA PGVRRTPEEA
     AAGEVNLSSS DSPYHYTKVT YSQEDVDKLL HLTHYNVCNN QEQLLEALRQ AVQRRRQRRP
     H
//
